NCT02085005 - Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer | Biotech Hunter

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG

Capecitabine

Pharmaceutical form:tablet Route of administration: oral

DRUG

Aflibercept AVE0005

Pharmaceutical form:concentrate for infusion Route of administration: intravenous

DRUG

Oxaliplatin SR96669

Pharmaceutical form:solution for infusion Route of administration: intravenous